|
|
|
2024 UCI Anti-Cancer Challenge Kickoff
4:30 PM - 6:00 PM
UCI Research Park - UA Event Space (5141 California Avenue Ste. 250, Irvine, CA 92617)
Be the first to hear the announcement of newly funded projects and 2024 UCI Anti-Cancer Challenge updates. Program speakers include Dr. Richard Van Etten, director of the UCI Health Chao Family Comprehensive Cancer Center; Dr. Farshid Dayyani, medical director for the Stern Center for Cancer Clinical Trials & Research; and Dr. Maheswari Senthil, division chief of surgical oncology.
Register here
| | | |
|
|
UCI Center for Synthetic Biology Annual Symposium
8:30 AM - 6:00 PM
Interdisciplinary Science and Engineering Building
Register here
| | | |
|
|
Emerging Genetic Drivers of Human Diseases: A genome-wide spectrum of tandem repeat expansions in 338,963 humans
Speaker: Wei Li, PhD
10:00 AM - 11:00 AM
Host: Genomics, Research and Technology Hub (GRT Hub)
Join Zoom
| | | |
|
|
Scaling Drug Discovery: The Search for Selective Translation Modulators via Activity-Based DNA-Encoded Library Technology
Speaker: Brian Paegel, PhD
9:00 AM - 10:00 AM
Plumwood House, Room 166
Host: Department of Microbiology & Molecular Genetics
Contact Shanti Iyer to join via Zoom
| | |
Belonging, Equity and Empowerment (BEE) Scene | |
Accepting Nominations! Learning about each other cultivates an inclusive environment where everyone feels empowered to contribute and succeed. Nominate a colleague for a spotlight showcasing their unique stories beyond their roles at the CFCCC. Faculty, staff, and self-nominations are encouraged.
| |
Learn more about Claudia Benavente, PhD, UC Irvine School of Pharmacy & Pharmaceutical Sciences Associate Professor and Deputy Associate Director for Cancer Research Training & Education Coordination at the CFCCC, as she shares her insights on the impact of community support for driving new discoveries in cancer research. Claudia's work has been twice funded by the UCI Anti-Cancer Challenge and she will be among several researchers sharing project updates at the 2024 Ant-Cancer Challenge Kickoff and and Grant Awards Announcement on Thursday, May 30! | |
|
Giovanna Falcon
Temporary Administrative Assistant, Office of Community, Outreach & Engagement
gfalcon1@hs.uci.edu | 714-456-5408
Giovanna holds over 6 years of experience in various administrative capacities, including her recent position as the Executive Assistant to the Dean and Head of Curtin Law School at Curtin University in Perth, Western Australia. In this role, she was the first point of contact and provided extensive support for both academic and legal events, handled a high volume of logistics and travel requests, and acted as the Executive Officer for the CLS External Advisory Board and assisted operations in the John Curtin Law Clinic, which provides legal advice and assistance to members of the community who could not afford to obtain paid legal assistance. Please join us in welcoming Giovanna to our team!
| |
|
|
Helen Tam
Clinical Research Coordinator, Breast Team/Team I
htam4@hs.uci.edu | 714-456-6907
Helen has a BS in Health Science from CSDH. She brings 13+ years of oncology research coordination experience from a private oncology practice and from Providence Medical Foundation. She has experience with coordinating various oncology disease sites—from solid to liquid tumors—such as pre-screening, eligibility reviews, consenting, preparing for monitoring visits, and data entry. Helen also has worked on Epic Beacon builds and study startup tasks. Since she joined our unit earlier this month, she has been assisting with pre-screening, contacting patients, and getting acquainted with the studies she will be taking over. Welcome, Helen!
| |
|
|
Alice Ting
Clinical Research Coordinator, Team B - Hematology
yunpeit@hs.uci.edu | 714-509-2414
Since joining the CTU in 2022 as an Assistant Research Data Coordinator, Alice has consistently demonstrated exceptional teamwork, a positive attitude, and a readiness to embrace new challenges. She has taken to learning multiple new disease processes very quickly, leveraging her clinical background in pharmacy. Most recently, she has taken the initiative to serve as a trusted primary contact/liaison for our pharmaceutical trial sponsors to address studies with many patients as well as patients with complex treatment journeys. Her ability to handle complex data requests with both tact and efficiency has not only enhanced our operations as a team; it has tremendous value in strengthening our continued relationships with these sponsors. Congratulations on your new position, Alice!
| |
|
|
UC Pancreatic Cancer Consortium receives $1 million gift to support early detection
The UC Pancreatic Cancer Consortium is delighted to announce a $1 million gift from the Bern Schwartz Family Fund at Vanguard Charitable to support a UC-wide 5-year program. The donor's advised fund is named in honor of Bern Schwartz (1914-1978) an American businessman and portrait photographer.
The award will focus on three main areas:
- Building a UC-wide biobank of samples from patients with early-stage pancreatic cancer and using these to validate novel blood-based early detection tests
- Enhancing standard screening with AI-driven MRI for groups at high risk of developing pancreatic cancer
- Supporting discovery of new early detection tests for pancreatic cancer
Pancreatic cancer is currently the third leading cause of cancer-related death in the USA and is on target to become the second leading cause by the end of the decade. The 5-year survival rate for patients diagnosed with disease localized to the pancreas is 44%, but for those patients diagnosed once the cancer has spread throughout the body it is just 3%. Early detection is likely to have the biggest impact on survival.
The UC Pancreatic Cancer Consortium consists of interdisciplinary scientists from the five UC Comprehensive Cancer Centers, working together to improve care and increase the cure rate for patients with pancreatic cancer.
| |
|
Congratulations to the 2024 Service Awards Honorees!
Thank you for being a valuable member of the CFCCC team and for your many wonderful years of service! Learn more about the June 18 service awards ceremony at the Bren Events Center.
15 Years: Hai Tran
10 Years: Samantha Anderson, Stephanie Fernandez, Blake Johnson
5 Years: Jennifer Avalos, Amber Camero, Hazel Dimasuay, David Guadian, Luisa Mejia Aguilar, Celest Ramirez
3 Years: Amanda Atkinson, Jasmine Balangue, Myca Cabuay, Kimberly Castellanos, Jenny Choe, Kennington Cung, Kristian Ghio, Mason Huynh, Vy Le, Kara McBride, Erin Palmer-Torrison, Robert Park, Immaculate Rivera, Stephanie Ross, Billy Sanchez
| |
|
Congratulations to the 2024 Cancer Health Disparity and Interventional Studies Award Recipients!
The award is designed to support research projects and investigator-initiated interventional clinical trials that address cancer health disparities in Orange County. Visit the awards site for abstracts of each project.
- Michael A. Hoyt, PhD | Reducing Disparities in the Adverse Impact of Cancer in Young
- Adult Latino Men
- Hari Keshava, MD | Lung Cancer Screening of Family Members of Patients with Mutation-Driven Lung Cancer
- Gelareh Sadigh, MD | Addressing Financial and Social Needs Among Patients with Cancer
- Jessica Shiu, MD, PhD | Why Do Hispanic Patients Present with Late-Stage Melanoma at a Younger Age?
| |
|
Experimental Tissue Shared Resource (ETR) Offers Custom Tissue Microarray and Brightfield Whole Slides Scanning
The ETR is excited to discuss your project’s study design and tissue needs. We can now create custom tissue microarrays (TMA) with tissue you provide or human tissue remnants and scan whole histology slides at 40X. Selection of optimal representative tissue regions can be performed by our pathologist.
We can provide histology support for special transcriptomics platforms supported by GTH Share Resource
Questions? Contact Delia Tifrea, ETR Core Manager, 714-872-1093.
| |
|
The Biobehavioral Shared Resource (BBSR) Consultation & Comprehensive Project Request is Live
The BBSR is excited to discuss your project’s study design and needs, as well as see how our new menu of services can best support your project goals.
During our “Consultation Meeting” we’ll learn more about your project and how the BBSR can support your team. Ready to schedule? Complete the "Consultation Request" on iLab.
Questions? Contact Jose Lechuga, BBSR Core Manager.
| |
|
Biostatistics Shared Resource - In-person Walk-in or Zoom Consultations Available
Informal statistical in-person walk-in or via Zoom consultations are available to discuss your study design and statistical needs.
With Wen-pin Chen, MS, Senior Statistician & Manager for BSR:
With Thomas H. Taylor, PhD, Principal Statistician for BSR:
-
Every Wednesday from 2:00 - 3:00 PM via Zoom | No pre-booking necessary, drop in here
With Dabao Zhang, PhD, Principal Statistician for BSR:
-
Every Tuesday from 1:00 - 2:00 PM via Zoom | Pre-booking is encouraged although it is not necessary (email Dr. Zhang), drop in here
| |
|
For a curated list of internal, federal and foundation funding opportunities, please refer to CFCCC's Funding Opportunities webpage. Highlighted funding opportunities are listed below.
UCI & UC FUNDING OPPORTUNITIES
UCI CFCCC: A1 Bridge
Up to $20k in bridge funding to investigators who have received scores on NIH grant applications (i.e., not triaged) that have missed the funding pay line and will be resubmitted.
Applications: Due on a rolling basis
Learn More and Apply >>
| |
|
FOUNDATION FUNDING OPPORTUNITIES
St. Baldrick's Foundation Fall Grant Cycle
Focus area: childhood cancers
$25k - $50k
Letter of Intent: July 8, 2024
Learn More and Apply >>
| |
|
OTHER NON-FEDERAL FUNDING OPPORTUNITIES
California Breast Cancer Research Program (CBCRP)
Focus area: artificial light pollution and breast cancer
$150k / 6 months
Applications: August 8, 2024
Learn More and Apply >>
| |
|
FEDERAL FUNDING OPPORTUNITIES
NCI SBIR Innovative Concept Award
Focus: small businesses that are developing highly transformative technologies with the potential to create new and improved methods for research, prevention, detection, and treatment of pediatric and/or rare cancers
Up to $300k
Deadline for Receipt of White Papers: June 5, 2024
Learn More and Apply >>
NCI Notice of Special Interest (NOSI): Telehealth Research in Cancer Care
First available due date: June 5, 2024
Learn More and Apply >>
NCI Worta McCaskill-Stevens Career Development Award for Community Oncology and Prevention Research (K12 Clinical Trial Optional)
Applications: June 18, 2024
Learn More and Apply >>
Congressionally Directed Medical Research Programs (CDMRP)
FY24 Breast Cancer Research Program (BCRP) - next deadline May 30, 2024
FY24 Lung Cancer Research Program (LCRP) - next deadline June 17, 2024
FY24 Ovarian Cancer Research Program (OCRP) - next deadline June 3, 2024
FY24 Pancreatic Cancer Research Program (PCRP) - next deadline June 28, 2024
(NEW) FY24 Melanoma Research Program (MRP) - next deadline July 29, 2024
Bone Marrow Failure Research Program | Pre-Announcement (multiple awards)
Learn More >>
Kidney Cancer Research Program | Pre-Announcement (multiple awards)
Learn More >>
Prostate Cancer Research Program | Pre-Announcement (multiple awards)
Learn More >>
Peer-Reviewed Cancer Research Program (PRCRP) | Pre-Announcement (multiple awards)
Learn More >>
| | |
|
|
Dr. Aryanna Sepassi, Dr. Alexandre Chan Publish Findings on "Rural-Urban Disparities in Colorectal Cancer Screening, Diagnosis, Treatment, and Survivorship Care"
In a study published in The Oncologist, Dr. Aryana Sepassi, Dr. Alexandre Chan, and their fellow researchers shared their findings regarding colorectal cancer concerns among rural residents, as compared to people living in urban settings.
Read More >>
| | | | |
